Holen Sie sich die Stockscreener-App
0.3305
7.94%
-0.0285
Handel nachbörslich:
.33
-0.0005
-0.15%
Schlusskurs vom Vortag:
$0.359
Offen:
$0.356
24-Stunden-Volumen:
854.84K
Relative Volume:
0.20
Marktkapitalisierung:
$10.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-19.43%
1M Leistung:
-44.46%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.3111
$0.356
1-Wochen-Bereich:
$0.3111
$0.4299
52-Wochen-Spanne:
$0.3111
$2.22
Profusa Inc Stock (PFSA) Company Profile
Firmenname
Profusa Inc
Sektor
Branche
Telefon
212-494-9022
Adresse
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Vergleichen Sie PFSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.3305 | 12.79M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Profusa Inc Aktie (PFSA) Neueste Nachrichten
Profusa's Strategic Position in Digital Health Innovation - AInvest
Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Digital Health Pioneer Profusa to Showcase Continuous Biochemistry Monitoring Tech at Major Conference - Stock Titan
Profusa announces commercial and clinical collaboration with head of angiography, Medical University of Graz, Austria - MarketScreener
Profusa Announces Commercial and Clinical Collaboration - GlobeNewswire
Leading Vascular Center Adopts Profusa's Real-Time Oxygen Monitoring Tech for 1,500 Annual Procedures - Stock Titan
Profusa amends purchase agreement and note terms for convertible debt tranches - Investing.com Australia
Profusa Restructures Securities Agreement for Enhanced Flexibility - AInvest
Profusa Restructures Securities Agreement for Flexibility - MSN
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket - Benzinga
Profusa Appoints New CFO and Lead Director - TipRanks
Profusa, Inc. shares fall 8.88% intraday despite adding seasoned finance executive Fred Knechtel as CFO. - AInvest
Profusa adds former VA chief and Fortune 500 executive to leadership - Investing.com
Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO - The Manila Times
Profusa Welcomes Former Acting U.S. Veterans Affairs - GlobeNewswire
Profusa, Inc. Appoints Fred Knechtel as CFO - MarketScreener
Profusa, Inc. shares rise 4.26% premarket after announcing a distributor for its tissue oxygen technology. - AInvest
Profusa Inc (NASDAQ: PFSA) Establishes a distributor partner in Spain for Lumee Oxygen platform - MarketScreener
Profusa announces initial $1 million bitcoin investment to initiate its digital asset treasury strategy - MSN
Profusa, Inc. SEC 10-Q Report - TradingView
Profusa Announces Nasdaq Listing and Growth Plans - TipRanks
Strategic partnerships have been essential to Profusa’s progress: CEO Ben Hwang - AlphaStreet
Profusa shares strategy update as it transitions to public company By Investing.com - Investing.com South Africa
Profusa shares strategy update as it transitions to public company - Investing.com India
Profusa, Inc. Outlines Growth Strategy and Milestones in Shareholder Letter Following Nasdaq Listing - Quiver Quantitative
Profusa Achieves Milestones, Commits to Groundbreaking Biochemistry Tech. - AInvest
Profusa, Inc. Provides Strategy Overview and Business Update for Investors - Bluefield Daily Telegraph
Profusa Reports Q1 2026 Commercial Launch in Europe for Tissue Oxygen Monitoring Platform - AInvest
Digital Health Pioneer Profusa Unveils $10B Market Strategy for Biochemistry Platform | PFSA Stock News - Stock Titan
Profusa, Inc. Secures Lumee?? Oxygen Platform Distributor in Spain - MarketScreener
Profusa signs LOI for distribution of Lumee Oxygen platform in Spain - Investing.com Australia
Profusa Secures Lumee™ Oxygen Platform Distributor in Spain - The Manila Times
Profusa Signs Letter of Intent for Lumee Oxygen Distribution in Spain. - AInvest
Profusa Targets 300,000 Annual European Procedures with Spanish Distribution Partnership - Stock Titan
Profusa stock falls after announcing $1 million Bitcoin investment By Investing.com - Investing.com South Africa
Profusa invests $1 million in bitcoin as part of treasury strategy By Investing.com - Investing.com Nigeria
Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy - The Manila Times
Profusa makes $1 million bitcoin investment as part of treasury strategy By Investing.com - Investing.com South Africa
Profusa Announces Initial $1M Bitcoin Investment Under Its Treasury Strategy - 富途牛牛
Digital Health Leader Makes Historic $1M Bitcoin Investment, Partners With BlockFills for Crypto Treasury - Stock Titan
Profusa Stock Plunges 12.1% Amid Purchase Agreement Concerns - AInvest
Profusa announces the launch of a $100 million Bitcoin Global Strategy. - 富途牛牛
Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Finanzdaten der Profusa Inc-Aktie (PFSA)
Es liegen keine Finanzdaten für Profusa Inc (PFSA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):